Last time we talked about our view on proteomics right now, and today we are introducing you to the Evosep One – a novel separation solution designed for fast and robust separation of omics samples in large clinical cohort studies (primarily proteomics and metabolomics).
OPTIMIZED METHODS FOR FOR FAST HIGH-PERFORMANCE SEPARATION
We don’t think today’s ultrahigh pressure, low-flow LC systems will ever be robust enough to operate in clinical labs. As a result, the Evosep One has been designed specifically to address and eliminate the prevalent challenges associated with throughput and robustness of nano-flow LC-MS workflows while maintaining sufficient sensitivity and resolving power for clinical omics applications. The recently introduced Evosep One provides:
- 10x reduction in sample-to-sample carry over
- >30.000 injection service interval for increased robustness
- 1-3 minutes sample cycle overhead regardless of gradient for high throughput and MS utilization
- Chromatographic performance (peak capacity) comparable to conventional high-end and low-flow HPLC’s
Taken together, these features enable short gradients for reliable high throughput in large cohort studies.
WANT TO KNOW MORE?
→ Click here for more detailed information about the Evosep One.
→ Continue to the fourth and last blog post.